Overview

KYRA is an AI‑powered intelligence platform by Chryselys designed for the pharmaceutical and life sciences industry. Built on advanced GenAI and data analytics, KYRA synthesizes structured trial data, unstructured scientific literature, and internal data sources to deliver context‑aware clinical and commercial insights. It supports clinical trial design, protocol feasibility, investigator selection, market performance tracking, segmentation, and strategic decision‑making. KYRA’s contextual GenAI reasoning elevates traditional analytics by linking insights directly to actionable recommendations with traceability and evidence.

Features and Capabilities

• Clinical Intelligence: Enables smarter trial planning, inclusion/exclusion criteria optimization, and protocol feasibility analysis using integrated data from clinical registries and literature.
• Data Integrity & Quality: Detects and corrects anomalies in pharma data, ensuring reliable decision inputs.
• GenAI‑Driven Insights: Combines structured and unstructured datasets for narrative insights and evidence‑backed answers.
• Investigator & Site Assessment: Assesses historical participation, therapeutic relevance, and access to patient cohorts for site and investigator selection.
• Commercial Intelligence: Synthesizes prescription behavior, engagement signals, and performance benchmarks to refine targets and field strategies.
• Field Execution Analytics: Highlights performance gaps, correlates rep activity with business outcomes, and recommends next best actions.
• Segmentation & Targeting: Automates micro‑segmentation and priority identification across geographies and specialties.
• Brand & Campaign Analytics: Links omnichannel actions with uptake metrics and market outcomes.
• Stack Integration: Works with existing CRM and analytics stacks.